Glass House Brands (GLAS) Enterprise Value (2020 - 2026)
Glass House Brands' (GLAS) quarterly Enterprise Value came in at -$19.8 million in Q1 2026, up 75.4% year-on-year from -$11.3 million in Q1 2025, and down 69.86% on a QoQ basis from -$11.7 million in Q4 2025.
Glass House Brands (GLAS) Enterprise Value (2020 - 2026) Analysis & Trends
Glass House Brands (GLAS) has 7 years of Enterprise Value data on file, last reported at -$19.8 million in Q1 2026.
- On a quarterly basis, Enterprise Value rose 75.4% year-over-year to -$19.8 million in Q1 2026; TTM through Mar 2026 was -$19.8 million, a 75.4% increase from a year earlier, with the FY2025 full-year figure at -$11.7 million, up 84.52% from the prior year.
- Enterprise Value for Q1 2026 stood at -$19.8 million, down from -$11.7 million in the prior quarter.
- Over the last five years, Enterprise Value for GLAS reached as high as -$11.7 million in Q4 2025 and fell as low as -$89.2 million in Q2 2025.
- Historically, Enterprise Value has averaged -$41.5 million across 5 years, with a median of -$28.1 million in 2022.
- Across the five-year window, Enterprise Value surged 92.48% in 2022 and slumped 330.65% in 2024, its largest moves.
- Year by year, Enterprise Value stood at -$18.4 million in 2022, then gained by 4.79% to -$17.5 million in 2023, then slumped by 330.65% to -$75.5 million in 2024, then surged by 84.52% to -$11.7 million in 2025, then slumped by 69.86% to -$19.8 million in 2026.
- Per Business Quant data, the three most recent Enterprise Value figures were -$19.8 million in Q1 2026, -$11.7 million in Q4 2025, and -$21.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | -1.86 Bn |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | -3.74 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | -1.94 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | -4.05 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | -2.15 Bn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | -3.97 Mn |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | -1.80 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | -1.32 Bn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | -428.00 Mn |
| 10 | Glass House Brands | 873.84 Mn | 845.91 Mn | 10.02 Mn | -19.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19.85 Mn |
| Dec 31, 2025 | -11.68 Mn |
| Sep 30, 2025 | -21.89 Mn |
| Jun 30, 2025 | -89.20 Mn |
| Mar 31, 2025 | -80.68 Mn |
| Dec 31, 2024 | -75.47 Mn |
| Sep 30, 2024 | -72.13 Mn |
| Jun 30, 2024 | -59.06 Mn |
| Mar 31, 2024 | -53.79 Mn |
| Dec 31, 2023 | -17.52 Mn |
| Sep 30, 2023 | -58.28 Mn |
| Jun 30, 2023 | -35.83 Mn |
| Mar 31, 2023 | -26.65 Mn |
| Dec 31, 2022 | -18.41 Mn |
| Sep 30, 2022 | -17.68 Mn |
| Jun 30, 2022 | -18.52 Mn |
| Mar 31, 2022 | -28.05 Mn |
| Dec 31, 2021 | -54.26 Mn |
| Sep 30, 2021 | -28.86 Mn |
| Jun 30, 2021 | -134.28 Mn |